Read This Before Buying Invictus MD Strategies Corp. (CVE:GENE) Shares

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we’d be remiss not to mention that insider sales have been known to precede tough periods for a business. So we’ll take a look at whether insiders have been buying or selling shares in Invictus MD Strategies Corp. (CVE:GENE).

What Is Insider Buying?

It’s quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, such insiders must disclose their trading activities, and not trade on inside information.

Insider transactions are not the most important thing when it comes to long-term investing. But it is perfectly logical to keep tabs on what insiders are doing. For example, a Harvard University study found that ‘insider purchases earn abnormal returns of more than 6% per year.’

View our latest analysis for Invictus MD Strategies

The Last 12 Months Of Insider Transactions At Invictus MD Strategies

In the last twelve months, the biggest single sale by an insider was when the Chief Science Officer, Brenda Dixon, sold CA$447k worth of shares at a price of CA$2.25 per share. While we don’t usually like to see insider selling, it’s more concerning if the sales take price at a lower price. The silver lining is that this sell-down took place above the latest price (CA$0.49). So it may not shed much light on insider confidence at current levels. Notably Brenda Dixon was also the biggest buyer, having purchased CA$213k worth of shares.

In total, Invictus MD Strategies insiders sold more than they bought over the last year. You can see the insider transactions (by individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

TSXV:GENE Recent Insider Trading, May 30th 2019
TSXV:GENE Recent Insider Trading, May 30th 2019

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: insiders have been buying them).

Insider Ownership of Invictus MD Strategies

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 9.4% of Invictus MD Strategies shares, worth about CA$5.7m, according to our data. We do generally prefer see higher levels of insider ownership.

So What Does This Data Suggest About Invictus MD Strategies Insiders?

There haven’t been any insider transactions in the last three months — that doesn’t mean much. Our analysis of Invictus MD Strategies insider transactions leaves us unenthusiastic. We also note that, as far as we can see, insider ownership is fairly low, compared to other companies. Therefore, you should should definitely take a look at this FREE report showing analyst forecasts for Invictus MD Strategies.

Of course Invictus MD Strategies may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.